Pharmaceutics & Novel Drug Delivery Systems

Biography

After graduating from Tongji Medical University in Wuhan in 1983, Dr. Tan became a graduate student and studied liver pathology. Then he went to Essen University in Germany, sponsored by the Volkswagen scholarship, to study mesothelioma (1987-1990). After that, he participated in the Human Genome Project at Columbia University in New York (1990-1994). Subsequently, Dr. Tan was a resident and then a chief resident at Yale University Medical Center (1994-1998). He continued as an oncologic pathology fellow at Memorial Sloan-Kettering Cancer Center in New York (1998-1999). Dr. Tan was certified in AP and CP in 1998. He became an assistant professor at Roswell Park Cancer Center in Buffalo (1999-2004). He then worked as an associate professor at the University of Texas Health Center in Houston for two years before I joined MD Anderson Cancer Center in 2006. Dr. Tan was promoted to professor at MD Anderson in 2010, and became the first physician with Asia-heritage holding joint appointments in two clinical disciplines at MD Anderson . Sixty percent of his time is devoted to clinical services, and the rest is committed to research, education, and extramural activities. Dr. Tan’s research is focused on solid tumors, investigating potential biomarkers to assess survivorship and guide personalized medicine. Two of his \English books, Principles of Molecular Diagnostics and Personalized Cancer Medicine and Advances of Surgical Pathology in Gastric Cancer, have been translated into Chinese. Dr. Tan has published 200 peer-reviewed scientific articles and book chapters. Jointly, Dr. Tan has held three patents. He has frequently been invited to present at national and international conferences and seminars. Additionally, he has been invited to chair and co-chair conferences and sections of congresses. Furthermore, Dr. Tan has mentored numerous residents, fellows, and junior pathologists. As the senior medical consultant of Kingmed Medicine, Dr. Tan introduced ASCP to China in 2014, and he has been the honored director of the ASCP Training Center there. He serves on the CAP Committee of Molecular Marketing Panel. Dr. Tan has also served on the editorial board of eight peer-reviewed journals.

Research Interest

Solid tumors, investigating potential biomarkers to assess survivorship and guide personalized medicine